Tag: LPOXY Therapeutics
PLATTE CITY, Mo. — Funding to secure the upcoming trial of a Missouri biopharmaceutical company’s solution for preventing a deadly gut infection could prove critical in the fight against a condition that claims 80 U.S. lives daily, said Dr. Larry Sutton. LPOXY Therapeutics, which is developing a novel non-antibiotic therapy to prevent Clostridioides difficile infections…
Read More >
It’ll be a year for entrepreneurs on a mission. Many of the startups poised to make eye-catching headlines in 2025 also are working toward a better future — for the earth, for mothers, for people who love their pets, for Kansas Citians who’ve embraced the city’s craft community, and even for sports enthusiasts honing their…
Read More >
Editor’s note: Startland News editors selected 10 Kansas City scaling businesses to spotlight for its annual Startups to Watch list. Now in its 10th year, this feature recognizes founders and startups that editors believe will make some of the biggest, most compelling news in the coming 12 months. The following is one of 2025’s companies.…
Read More >
